(212) 203-2813 115 E. 57th St. STE 1210 • New York, NY 3675 E Tremont Ave • Bronx, NY

OUR MISSION STATEMENT

The Center for Clinical Studies is the official research division of the Ainsworth Institute and is committed to bringing the future of medicine to the forefront of today. By participating in research studies and clinical trials, our physicians are able to offer the most cutting edge treatments to our patients that are not yet available to the public at-large.

Who We Are

Our center conducts clinical trials and participates in the research and development of therapies and technologies that will allow the field of pain management to grow to be able to allow patients even better outcomes.

Our research department gives patients access to the most advanced technologies in existence and works to develop strategies in conjunction with industry experts to allow individuals the best care with the least risk.

What Sets Us Apart

The Center for Clinical Studies has thrust the Ainsworth Institute to the forefront of medicine and is what sets us apart from every other pain management center out there. No other private practice or academic institute in the area is as involved in research, clinical trials or publication as the Ainsworth Institute.

Current Clinical Trials & Research Studies

PRESS REGISTRY – Indirect Decompression of the Lumbar Spine Using an Interspinous Spacer to Treat Spinal Stenosis

The Ainsworth Institute has been selected to join a post-market study called the PRESS Registry which will examine the safety and LONG-TERM efficacy of the Superion™ Interspinous Spacer as a treatment for Lumbar Spinal Stenosis (LSS)

LSS is traditionally treated by a invasive procedure called a “laminectomy” which involves removing a large piece of bone on the spinal column to create more room for the spinal cord.  This procedure is very effective in many cases, however the chance of the procedure failing or causing the pain to get worse can be as high as 40%.  The recovery time for a laminectomy can be rough, it typcally requires an overnight stay in the hospital and it is irreversible.  The Superion™ Interspinous Spacer is an extremely effective alternative to a laminectomy and has shown efficacy out to 5-years.

ENROLLMENT OPEN

Spinal Stenosis, Spinal Stenosis Treatment, LSS, LSS Treatment, Pain Doctor New York

SEE IF YOU QUALIFY FOR THE STUDY

Spinal Stenosis, Spinal Stenosis Treatment, LSS, LSS Treatment, Pain Doctor New York

PRESS REGISTRY Indirect Decompression of the Lumbar Spine Using an Interspinous Spacer to Treat Spinal Stenosis

The Ainsworth Institute has been selected to join a post-market study called the PRESS Registry which will examine the safety and LONG-TERM efficacy of the Superion™ Interspinous Spacer as a treatment for Lumbar Spinal Stenosis (LSS). LSS is traditionally treated by a invasive procedure called a “laminectomy” which involves removing a large piece of bone on the spinal column to create more room for the spinal cord. This procedure is very effective in many cases, however the chance of the procedure failing or causing the pain to get worse can be as high as 40%. The recovery time for a laminectomy can be rough, it typcally requires an overnight stay in the hospital and it is irreversible. The Superion™ Interspinous Spacer is an extremely effective alternative to a laminectomy and has shown efficacy out to 5-years.

ENROLLMENT – OPEN

SEE IF YOU QUALIFY FOR THE STUDY

CLEAR STUDY – Long-Acting Corticosteroid for Treating Sciatica Pain from Herniated Discs in the Low Back

The Ainsworth Institute has been selected to join a Phase III clinical trial studying the safety and overall efficacy of a new compound designed to treat sciatica pain for up to 12-months with a single injection.

Epidural steroid injections have been the mainstay for treating sciatica (aka lumbar radiculopathy) for over 30-years.  While these treatments are extremely effective, the pain relieving effects can be short lived which leads to the need for several injections over the course of a year just to keep up.  This clinical trial will investigate an experimental medication that is purported to extend the effects of a standard epidural injection for up a year – thus eliminating the need for repeated injections.

ENROLLMENT OPEN

Sciatica Treatment, Pain Doctor New York, Pain Doctor NYC

SEE IF YOU QUALIFY FOR THE STUDY

Sciatica Treatment, Pain Doctor New York, Pain Doctor NYC

CLEAR STUDY Long-Acting Corticosteroid for Treating Sciatica Pain from Herniated Discs in the Low Back

The Ainsworth Institute has been selected to join a Phase III clinical trial studying the safety and overall efficacy of a new compound designed to treat sciatica pain for up to 12-months with a single injection. Epidural steroid injections have been the mainstay for treating sciatica (aka lumbar radiculopathy) for over 30-years. While these treatments are extremely effective, the pain relieving effects can be short lived which leads to the need for several injections over the course of a year just to keep up. This clinical trial will investigate an experimental medication that is purported to extend the effects of a standard epidural injection for up a year – thus eliminating the need for repeated injections.

ENROLLMENT – OPEN

SEE IF YOU QUALIFY FOR THE STUDY

HOPE TRIAL – Dorsal Root Ganglion (DRG) Stimulation for Chronic Pelvic Pain and Pudendal Neuralgia

The Ainsworth Institute is initiating a multi-center randomized, controlled trial on the use of DRG Stimulation to treat one of THE most painful and most difficult to treat pain syndromes known to man – Chronic Pelvic Pain (CPP).

DRG Stimulation has been nothing short of a revelation for patients suffering from the likes of CRPS/RSD, knee pain, post surgical pain and groin pain.  Seeing the immense potential of this amazing therapy, Dr. Hunter pioneered the application of DRG Stimulation on pelvic pain/pudendal neuralgia, thereby discovering the neural targets for treating this incredibly elusive syndrome.  The Ainsworth Institute will be heading up this study that will include a number of other academic institution across the nation.

ENROLLMENT Pending

Pudendal Neuralgia, Pelvic Pain, Chronic Pelvic Pain, Pudendal Neuralgia Treatments

SEE IF YOU QUALIFY FOR THE STUDY

 

Pudendal Neuralgia, Pelvic Pain, Chronic Pelvic Pain, Pudendal Neuralgia Treatments

HOPE TRIAL Dorsal Root Ganglion (DRG) Stimulation for Chronic Pelvic Pain and Pudendal Neuralgia

The Ainsworth Institute is initiating a multi-center randomized, controlled trial on the use of DRG Stimulation to treat one of THE most painful and most difficult to treat pain syndromes known to man – Chronic Pelvic Pain (CPP). DRG Stimulation has been nothing short of a revelation for patients suffering from the likes of CRPS/RSD, knee pain, post surgical pain and groin pain. Seeing the immense potential of this amazing therapy, Dr. Hunter pioneered the application of DRG Stimulation on pelvic pain/pudendal neuralgia, thereby discovering the neural targets for treating this incredibly elusive syndrome. The Ainsworth Institute will be heading up this study that will include a number of other academic institution across the nation.

ENROLLMENT – Pending

SEE IF YOU QUALIFY FOR THE STUDY

 

BENEFIT-02 STUDY – A Brand New Spinal Cord Stimulation Technology for Treating Chronic Low Back and/or Leg Pain

Biotronik is conducting a phase I clinical trial on their stimulation system and its efficacy for treating low back and leg pain.

Spinal cord stimulation has been used to treat various types of chronic pain for decades.  While many have benefited from this therapy over time, there remains a great deal of room for improvement with regards to percentage of people who respond and the degree of relief one can achieve.  In this clinical trial, patients will complete a standard commercial stimulator trial – after which, they will be able to extend their trial experience for an additional 12-days using the experimental Biotronik system while awaiting their implant.

ENROLLMENT OPEN

Saluda, EVOKE, clinical trial low back pain, clinical trial leg pain

SEE IF YOU QUALIFY FOR THE STUDY

Saluda, EVOKE, clinical trial low back pain, clinical trial leg pain

BIOTRONIK-02 STUDY – A Brand New Spinal Cord Stimulation Technology for Treating Chronic Low Back and/or Leg Pain

Biotronik is conducting a phase I clinical trial on their stimulation system and its efficacy for treating low back and leg pain. Spinal cord stimulation has been used to treat various types of chronic pain for decades. While many have benefited from this therapy over time, there remains a great deal of room for improvement with regards to percentage of people who respond and the degree of relief one can achieve. In this clinical trial, patients will complete a standard commercial stimulator trial – after which, they will be able to extend their trial experience for an additional 12-days using the experimental Biotronik system while awaiting their implant.

ENROLLMENT – OPEN

SEE IF YOU QUALIFY FOR THE STUDY

HI-FI STUDY – Ultra-High Pulse Widths Stimulation for Chronic Low Back and/or Leg Pain

Nuvectra is conducting a phase IV, post market study, clinical trial on their High Fidelity Stimulation System, specifically examining the use of Ultra-High Pulse Width Stimulation to treat low back and leg pain.

Spinal cord stimulation has been used to treat various types of chronic pain for decades.  While many have benefited from this therapy over time, there remains a great deal of room for improvement with regards to percentage of people who respond and the degree of relief one can achieve.  In this clinical trial, we will be studying a brand new method for treating pain.

ENROLLMENT OPEN

Saluda, EVOKE, clinical trial low back pain, clinical trial leg pain

SEE IF YOU QUALIFY FOR THE STUDY

Saluda, EVOKE, clinical trial low back pain, clinical trial leg pain

HI-FI STUDY – Ultra-High Pulse Widths Stimulation for Chronic Low Back and/or Leg Pain

Nuvectra is conducting a phase IV, post market study, clinical trial on their High Fidelity Stimulation System, specifically examining the use of Ultra-High Pulse Width Stimulation to treat low back and leg pain. Spinal cord stimulation has been used to treat various types of chronic pain for decades. While many have benefited from this therapy over time, there remains a great deal of room for improvement with regards to percentage of people who respond and the degree of relief one can achieve. In this clinical trial, we will be studying a brand new method for treating pain.

ENROLLMENT – OPEN

SEE IF YOU QUALIFY FOR THE STUDY

TISSUETECH STUDY – Amniotic Tissue Therapy for Chronic Back Pain

In 2019, The Ainsworth Institute will be participating in a Phase 1 Clinical Trial studying the safety and potential efficacy of using amniotic tissue to treat chronic low back pain.  Amniotic tissue is rich in growth factors and promotes tissue repair.

There are many potential causes for low back pain, one of the most common causes is the facet joint – the joint hear and feel when we crack our backs.  The facet joint can become arthritic like any other joint in the body and lose cartilage causing the bony surfaces to grind…thus causing inflammation and pain.  This study will examine using amniotic tissue to regenerate damaged/painful facets and eliminate low back pain.

ENROLLMENT Pending

SEE IF YOU QUALIFY FOR THE STUDY

 

 

TISSUETECH STUDY – Amniotic Tissue Therapy for Chronic Back Pain

In 2019, The Ainsworth Institute will be participating in a Phase 1 Clinical Trial studying the safety and potential efficacy of using amniotic tissue to treat chronic low back pain. Amniotic tissue is rich in growth factors and promotes tissue repair. There are many potential causes for low back pain, one of the most common causes is the facet joint – the joint hear and feel when we crack our backs. The facet joint can become arthritic like any other joint in the body and lose cartilage causing the bony surfaces to grind…thus causing inflammation and pain. This study will examine using amniotic tissue to regenerate damaged/painful facets and eliminate low back pain.

ENROLLMENT – Pending

SEE IF YOU QUALIFY FOR THE STUDY

 

 

TISSUE GENE STUDY – Stem Cell Therapy for Chronic Knee Pain

The Ainsworth Institute of Pain Management has been selected to join a phase 3 clinical trial studying the safety and efficacy of a type of stems cell called a “juvenile chondrocyte” for the treatment of chronic knee pain.

Chronic knee osteoarthritis (OA) is one of the most common diseases of advanced age with as many as 1 million sufferers in the United States alone. Typically, the only definitive treatments are injections – and if injections are unsuccessful, a knee replacement. Close to 700,000 people received knee replacements each year according to the CDC. This study will investigate the use of stem cells as a safe alternative to surgery.

ENROLLMENT OPEN

SEE IF YOU QUALIFY FOR THE STUDY

 

TISSUE GENE STUDY – Stem Cell Therapy for Chronic Knee Pain

The Ainsworth Institute of Pain Management has been selected to join a phase 3 clinical trial studying the safety and efficacy of a type of stems cell called a “juvenile chondrocyte” for the treatment of chronic knee pain. Chronic knee osteoarthritis (OA) is one of the most common diseases of advanced age with as many as 1 million sufferers in the United States alone. Typically, the only definitive treatments are injections – and if injections are unsuccessful, a knee replacement. Close to 700,000 people received knee replacements each year according to the CDC. This study will investigate the use of stem cells as a safe alternative to surgery.

ENROLLMENT – OPEN

SEE IF YOU QUALIFY FOR THE STUDY

 

VIVEX STUDY – Stem Cell Therapy for Chronic Discogenic Low Back Pain

The Ainsworth Institute of Pain Management has been selected to join a phase 3 clinical trial studying the safety and efficacy of mesenchymal stems cells with a nucleus fibrosis scaffolding for the treatment of chronic low back back pain.

Low back pain affects 9 out of 10 Americans and is the 5th most common reason to go to the doctor. This trial will study the use of stem cells to potentially repair damaged spinal discs and decrease low back pain.  It is being conducted in several cities around the country; we are the only cite in the trip-state area!

ENROLLMENT Closed

SEE IF YOU QUALIFY FOR THE STUDY

 

VIVEX STUDY – Stem Cell Therapy for Chronic Discogenic Low Back Pain

The Ainsworth Institute of Pain Management has been selected to join a phase 3 clinical trial studying the safety and efficacy of mesenchymal stems cells with a nucleus fibrosis scaffolding for the treatment of chronic low back back pain.

Low back pain affects 9 out of 10 Americans and is the 5th most common reason to go to the doctor. This trial will study the use of stem cells to potentially repair damaged spinal discs and decrease low back pain. It is being conducted in several cities around the country; we are the only cite in the trip-state area!

ENROLLMENT – CLOSED

SEE IF YOU QUALIFY FOR THE STUDY

 

EVOKE STUDY – Closed Loop Stimulation for Chronic Low Back and/or Leg Pain

Our institute has been chosen to participate in the extremely prestigious EVOKE study – a phase 3 clinical trial on a device that can communicate with the spinal cord and adapt and pain patterns change.  We are 1 of just 11 sites selected to take part in this historic clinical trial. 

Spinal cord stimulation has been used to treat various types of chronic pain for decades.  While many have benefited from this therapy over time, there remains a great deal of room for improvement with regards to percentage of people who respond and the degree of relief one can achieve.  In this clinical trial, we will be studying a remarkable new stimulator technology that may very well change the face of medicine forever.

ENROLLMENT Closed

Saluda, EVOKE, clinical trial low back pain, clinical trial leg pain

SEE IF YOU QUALIFY FOR THE STUDY

Saluda, EVOKE, clinical trial low back pain, clinical trial leg pain

EVOKE STUDY – Closed Loop Stimulation for Chronic Low Back and/or Leg Pain

Our institute has been chosen to participate in the extremely prestigious EVOKE study – a phase 3 clinical trial on a device that can communicate with the spinal cord and adapt and pain patterns change. We are 1 of just 11 sites selected to take part in this historic clinical trial.

Spinal cord stimulation has been used to treat various types of chronic pain for decades. While many have benefited from this therapy over time, there remains a great deal of room for improvement with regards to percentage of people who respond and the degree of relief one can achieve. In this clinical trial, we will be studying a remarkable new stimulator technology that may very well change the face of medicine forever.

ENROLLMENT – CLOSED

SEE IF YOU QUALIFY FOR THE STUDY

MESOBLAST STUDY – Stem Cell Therapy for Chronic Discogenic Low Back Pain

The Ainsworth Institute of Pain Management has been selected to join a phase 3 clinical trial studying the safety and efficacy of mesenchymal stem cells for the treatment of chronic low back back pain.

Low back pain affects 9 out of 10 Americans and is the 5th most common reason to go to the doctor. This trial will study the use of stem cells to potentially repair damaged spinal discs and decrease low back pain.  It is being conducted in several cities around the country; we are the only cite in the trip-state area!

ENROLLMENT Closed

SEE IF YOU QUALIFY FOR THE STUDY

MESOBLAST STUDY – Stem Cell Therapy for Chronic Discogenic Low Back Pain

The Ainsworth Institute of Pain Management has been selected to join a phase 3 clinical trial studying the safety and efficacy of mesenchymal stem cells for the treatment of chronic low back back pain.

Low back pain affects 9 out of 10 Americans and is the 5th most common reason to go to the doctor. This trial will study the use of stem cells to potentially repair damaged spinal discs and decrease low back pain. It is being conducted in several cities around the country; we are the only cite in the trip-state area!

ENROLLMENT – CLOSED

SEE IF YOU QUALIFY FOR THE STUDY

TARGET Study – Dorsal Root Ganglion Stimulation for the Treatment of Complex Regional Pain Syndrome (CRPS)

St. Jude Medical is conducting a phase IV, post market study, clinical trial on the DRG stimulator. The FDA recently approved this amazing therapy on February 2016 for the treatment of Complex Regional Pain Syndrome (CRPS).

The phase III clinical trial, known as the ACCURATE study, showed that DRG stimulation was effective in 93.3% of patients with CRPS. The TARGET study is being conducted at a handful of sites around the United States – the Ainsworth Institute is the only site in New York State, or the tri-state area.

ENROLLMENT Open

DRG Stimulation, CRPS treatment, complex regional pain syndrome treatment, RSD treatment, reflex sympathetic dystrophy treatment, clinical trial

SEE IF YOU QUALIFY FOR THE STUDY

DRG Stimulation, CRPS treatment, complex regional pain syndrome treatment, RSD treatment, reflex sympathetic dystrophy treatment, clinical trial

TARGET Study – Dorsal Root Ganglion Stimulation for the Treatment of Complex Regional Pain Syndrome (CRPS)

St. Jude Medical is conducting a phase IV, post market study, clinical trial on the DRG stimulator. The FDA recently approved this amazing therapy on February 2016 for the treatment of Complex Regional Pain Syndrome (CRPS).

The phase III clinical trial, known as the ACCURATE study, showed that DRG stimulation was effective in 93.3% of patients with CRPS. The TARGET study is being conducted at a handful of sites around the United States – the Ainsworth Institute is the only site in New York State, or the tri-state area.

ENROLLMENT Open

SEE IF YOU QUALIFY FOR THE STUDY

GRATIFY-1 STUDY – Genicular Radiofrequency Ablation (RFA) To Improve Post-Op Function & Recovery

In some cases, knee surgery is unavoidable – despite our best efforts. Our center is investigating the use of conventional RFA on the knee before surgery to see if patients have improved pain and recovery after surgery.

By using RFA on the genicular nerves outside the knee, our doctors can reduce pain inside the knee during the post-operative period – similar to the regional anesthesia given in the operating room just before the operation. The difference is this regional anesthesia will wear off in matter of hours, whereas RFA can last for months! With decreased pain after surgery, our doctors theorize patients will need less pain medication and make bigger strides in rehab and physical therapy leading to better function in a shorter period of time.

ENROLLMENT Pending

SEE IF YOU QUALIFY FOR THE STUDY

GRATIFY-1 Study – Radiofrequency Ablation (RFA) of the Knee before Surgery to Improve Post-Op Recovery

In some cases, knee surgery is unavoidable – despite our best efforts. Our center is investigating the use of conventional RFA on the knee before surgery to see if patients have improved pain and recovery after surgery.

By using RFA on the genicular nerves outside the knee, our doctors can reduce pain inside the knee during the post-operative period – similar to the regional anesthesia given in the operating room just before the operation. The difference is this regional anesthesia will wear off in matter of hours, whereas RFA can last for months! With decreased pain after surgery, our doctors theorize patients will need less pain medication and make bigger strides in rehab and physical therapy leading to better function in a shorter period of time.

ENROLLMENT – Pending

SEE IF YOU QUALIFY FOR THE STUDY

PHANTOM LIMB PAIN – High Frequency Nerve Block for Post-Amputation Pain: A Pivotal Study

The Ainsworth Institute of Pain Management has been selected to join an ongoing clinical trial that will investigate the use of Neuromodulation for the treatment of Phantom Limb Pain. This new technology will study the effect of a new type of electrode placed on the sciatic nerve combined with a new type of waveform not currently used to treat this painful syndrome in amputees. 

Our Center for Clinical Studies has partnered with the Department of Neurosurgery at Mount Sinai Hospital here in Manhattan to perform this amazing study.  The study itself will be conducted out of our flagship office in Manhattan.

ENROLLMENT Open

SEE IF YOU QUALIFY FOR THE STUDY

PHANTOM LIMB PAIN – High Frequency Nerve Block for Post-Amputation Pain: A Pivotal Study

The Ainsworth Institute of Pain Management has been selected to join an ongoing clinical trial that will investigate the use of Neuromodulation for the treatment of Phantom Limb Pain. This new technology will study the effect of a new type of electrode placed on the sciatic nerve combined with a new type of waveform not currently used to treat this painful syndrome in amputees. Our Center for Clinical Studies has partnered with the Department of Neurosurgery at Lenox Hill Hospital here in Manhattan to perform this amazing study. The study itself will be conducted out of our flagship office in Manhattan.

ENROLLMENT – Open

SEE IF YOU QUALIFY FOR THE STUDY

Previous Studies

KNEE PAIN STUDY – Coolief™ Cooled Radiofrequency Ablation to Treat Chronic Knee Pain

The Ainsworth Institute is investigating the use of Cooled Radiofrequency Ablation to treat chronic knee pain. Our center is one of just 12 sites throughout the country (the only center in the tri-state area) who has been asked to participate in this groundbreaking study.

Chronic knee osteoarthritis (OA) is one of the most common diseases of advanced age with as many as 1 million sufferers in the United States alone. Typically, the only definitive treatments are injections – and if injections are unsuccessful, a knee replacement. Close to 700,000 people received knee replacements each year according to the CDC. This study will investigate the use of Cooled Radiofrequency as a safe alternative to surgery.

ENROLLMENT Closed

KNEE PAIN STUDY – Coolief™ Cooled Radiofrequency Ablation to Treat Chronic Knee Pain

The Ainsworth Institute is investigating the use of Cooled Radiofrequency Ablation to treat chronic knee pain. Our center is one of just 12 sites throughout the country (the only center in the tri-state area) who has been asked to participate in this groundbreaking study.

Chronic knee osteoarthritis (OA) is one of the most common diseases of advanced age with as many as 1 million sufferers in the United States alone. Typically, the only definitive treatments are injections – and if injections are unsuccessful, a knee replacement. Close to 700,000 people received knee replacements each year according to the CDC. This study will investigate the use of Cooled Radiofrequency as a safe alternative to surgery.

ENROLLMENT – CLOSED

PHANTOM LIMB PAIN – Electrical Stimulation for the Treatment of Post-Amputation Pain Using the SPRINT System

The Ainsworth Institute of Pain Management has been selected to join an ongoing clinical trial that will investigate the use of Neuromodulation for the treatment of Phantom Limb Pain. This new technology will study the effect of an electrode placed percutaneously on the sciatic or femoral nerve to treat this painful syndrome in amputees. 

The device is the first of its kind and will be placed under ultrasound guidance.  Unlike most nerve stimulators, there is no battery implanted – rather the battery is worn outside the body, on the skin.  Another unique aspect of this device is that it is meant to be temporary: this means patients will have the leads placed only for a few weeks and then removed.

ENROLLMENT Closed

PHANTOM LIMB PAIN – Electrical Stimulation for the Treatment of Post-Amputation Pain Using the SPRINT System

The Ainsworth Institute of Pain Management has been selected to join an ongoing clinical trial that will investigate the use of Neuromodulation for the treatment of Phantom Limb Pain. This new technology will study the effect of an electrode placed percutaneously on the sciatic or femoral nerve to treat this painful syndrome in amputees. The device is the first of its kind and will be placed under ultrasound guidance. Unlike most nerve stimulators, there is no battery implanted – rather the battery is worn outside the body, on the skin. Another unique aspect of this device is that it is meant to be temporary: this means patients will have the leads placed only for a few weeks and then removed..

ENROLLMENTCLOSED

CREATE-1 STUDY – CRPS Treatment Evaluation 2 Study

The Ainsworth Institute has been selected to join a worldwide clinical trial studying the efficacy and safety of the medication AXS-02 for the treatment of Complex Regional Pain Syndrome Type 1 (CRPS-1).

CRPS (aka RSD) is painful and debilitating condition affecting both men and women. What causes CRPS is a mystery and without treatment, it can progress to the point where a simple gust of wind can bring a person to their knees from pain. This study is phase 3 clinical trial evaluating an oral medication as a potential treatment for CRPS.

ENROLLMENT Closed

CRPS Complex Regional Pain Syndrome Clinical Trial
CRPS Complex Regional Pain Syndrome Clinical Trial

CREATE-1 STUDY – CRPS Treatment Evaluation 2 Study

The Ainsworth Institute has been selected to join a worldwide clinical trial studying the efficacy and safety of the medication AXS-02 for the treatment of Complex Regional Pain Syndrome Type 1 (CRPS-1).

CRPS (aka RSD) is painful and debilitating condition affecting both men and women. What causes CRPS is a mystery and without treatment, it can progress to the point where a simple gust of wind can bring a person to their knees from pain. This study is phase 3 clinical trial evaluating an oral medication as a potential treatment for CRPS.

ENROLLMENT – CLOSED

Publications

Our physicians have been publishing in textbooks and peer-reviewed journals as well as lecturing around the country to share the results of our findings. These publications have been cited by additional researchers in their own studies as well as used by other pain management doctors to treat their own patients – thus aiding in the advancement of medicine and betterment of the field.

“Anatomy, Pathophysiology and Interventional Therapies for Chronic Pelvic Pain: A Review.” Hunter C, Stovall B, Chen G, Carlson J, Levy R.; Pain Physician. 2018; 21:147-167

“Spinal Cord Stimulation for the Treatment of Failed Neck Surgery Syndrome: Outcome of a Prospective Case Series.” Hunter C, Sayed D, Carlson J, Yang, A, Deer T.; Neuromodulation. 2018 Jul;21(5):495-503. doi: 10.1111/ner.12769.

“The Neuromodulation Appropriateness Consensus Committee (NACC) on Best Practices for Dorsal Root Ganglion Stimulation.” Deer T, et al.; Neuromodulation. 2018 Sep 24. doi: 10.1111/ner.12845.

“DRG FOCUS – A Multicenter Study Evaluating Dorsal Root Ganglion Stimulation and Predictors for Trial Success.” Hunter C, Sayed D, Lubenow T, Davis T, et al.; Neuromodulation. 2018 Aug 7. doi: 10.1111/ner.12796.

“Dorsal Root Ganglion Stimulation for Chronic Pelvic Pain: A Case Series and Technical Report on a Novel Lead Configuration.” Hunter C, Yang A.; Neuromodulation. 2018 Aug 1. doi: 10.1111/ner.12801

“Dorsal Root Ganglion Stimulation as a Salvage Treatment for Complex Regional Pain Syndrome Refractory to Dorsal Column Spinal Cord Stimulation: A Case Series,” Yang A, Hunter C.; Neuromodulation – Technology at the Neural Interface 2017; 20(7): 703-7.

“Selective Radiofrequency Ablation of the Dorsal Root Ganglion (DRG) as a Method for Predicting Targets for Neuromodulation in Patients With Post Amputation Pain: A Case Series,” Hunter C, Yang A, Davis T.; Neuromodulation Technology at the Neural Interface 2017; 20(7): 708-18.

“Neuromodulation of Pelvic Visceral Pain: Review of the Literature and Case Series of Potential Novel Targets for Treatment,” C. Hunter, N. Dave’, S. Diwan, T. Deer; Pain Practice. 13(1):3-17, 2013 Jan.

“A New Muscle Pain Detection Device to Diagnose Muscles as a Source of Back and/or Neck Pain,” C. Hunter, M. Dubois, S. Zou, W. Oswald, K. Coakley, M. Shebar, and A. M. Conlon; Pain Medicine. 11(1):35-43, 2010 Jan.

“Minimally Invasive Delivery of Stem Cells for Spinal Cord Injury: Advantages of the Lumbar Puncture Technique,” A. Bakshi, C. Hunter, S. Swanger, A. Lepore, and I. Fischer; Journal of Neurosurgery: Spine. 1(3):330-7, 2004 Oct.

Center for Clinical Studies

The Ainsworth Institute prides itself on having strong relationships with Industry & Medical Device Companies such as Abbott, Vertiflex, Saluda, TissueGene & Flowonix.  These relationships allow our doctors to stay on the cutting edge and help drive innovation in the field of pain management. Most importantly, it gives our Institute access to treatments not yet available to the general public within the United States.

[contact-form-7 id="4105" title="Make An Appointment"]
First Name
Last Name

Email Address
Phone Number

How may we help you?
Preferred Response Method

Phone CallEmail Reply

We will call or email you in response to your inquiries
during regular business hours (M-F, 9am-5pm ET)